The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Investigation of leptomeningeal disease in high grade glioma and characterization of molecular alterations.
 
Madison L. Shoaf
No Relationships to Disclose
 
Michael J. Glantz
Research Funding - cns pharmaceuticals (Inst); Denovo Biopharma (Inst); European Organisation for Research and Treatment of Cancer (EORTC) (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); ImmunoCellular Therapeutics (Inst); Ono Pharmaceutical (Inst); RTOG (Inst); Triphase Accelerator Corp (Inst)
 
Kyle J. Tuohy
No Relationships to Disclose
 
Frances Elaine Chow
No Relationships to Disclose
 
Joanne Xiu
Employment - Caris Life Sciences
 
Sonikpreet Aulakh
No Relationships to Disclose
 
David M. Ashley
Stock and Other Ownership Interests - Diverse Biotech; MAIA Biotechnology
Consulting or Advisory Role - Jackson Laboratory for Genomic Medicine; MAIA Biotechnology
Patents, Royalties, Other Intellectual Property - Methods for predicting tumor response to immunotherapy, U.S. Provisional application no. 62/787,508 filed January 2, 2019 Methods for predicting tumor response to immunotherapy, U.S. Provisional application no. 62/620,577 filed January 23, 2018
 
Eric S. Lipp
No Relationships to Disclose
 
Giselle Y. López
No Relationships to Disclose
 
Ashley Love Sumrall
Honoraria - Cardinal Health; Curio Science; Gerson Lehrman Group
Consulting or Advisory Role - Abbvie; Amgen; Athenex; Bayer; Exelixis; Merck; Novocure
Speakers' Bureau - Abbvie; Bayer; Bristol-Myers Squibb; Exelixis; Merck; Novocure; Prime Oncology
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Kura Oncology (Inst); Novocure (Inst); Oncoceutics (Inst)
Travel, Accommodations, Expenses - American Association of Neurological Surgeons; Bristol-Myers Squibb; Novocure; Xcenda
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences
 
Phillip Walker
Employment - Caris Life Sciences
 
David Spetzler
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Caris Life Sciences
Research Funding - Caris Life Sciences
Patents, Royalties, Other Intellectual Property - Caris Life Sciences holds and has pending patents with intellectual property interests relating to health and medicine.
Travel, Accommodations, Expenses - Caris Life Sciences
 
Theodore Nicolaides
Employment - Caris Life Sciences
 
Manmeet Singh Ahluwalia
Stock and Other Ownership Interests - CytoDyn; doctible; MedInnovate Advisors LLC; MimiVax
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - Anheart Therapeutics; Apollomics; Bayer; Bugworks; Cairn Therapeutics; Caris Life Sciences; GlaxoSmithKline; InSightec; Janssen; Menarini Group; Modifi Bio; NH TherAguix; Nuvation Bio; Prelude Therapeutics; Pyramid Biosciences; SDP Oncology; ViewRay; Voyager Therapeutics; Xoft
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst); Seagen (Inst)
 
Katherine B. Peters
Consulting or Advisory Role - Blue Earth Diagnostics; NuvOx Pharma; Ono Pharmaceutical; Sapience Therapeutics; SERVIER
Research Funding - Abbvie; BioMimetix; Novocure; NuvOx Pharma; Sapience Therapeutics; SERVIER; Varian Medical Systems
Other Relationship - Eisai Europe
(OPTIONAL) Uncompensated Relationships - Vivacitas Oncology